Cardiac Science Corporation (NASDAQ:
CSCX) is a global leader in developing, manufacturing and marketing
diagnostic and therapeutic cardiology products and services that protect
hearts and save lives.
Formed by the merger of Cardiac Science, Inc.
and Quinton Cardiology Systems, Inc. on September 1, 2005, the company
employs more than 550 people worldwide. Headquartered near Seattle,
WA, the company also has operations in California, Wisconsin, China,
Denmark and the United Kingdom.
The strategic benefits of the merger are significant
including substantial operational savings, stronger distribution
networks, enhanced customer service and greater technology capabilities
to support cutting-edge product development.
Three Trusted Brands, One New Company.
By leveraging the market leadership of its predecessor companies and
their established brands Burdick®, Powerheart®, and
Quinton® Cardiac Science Corporation is uniquely positioned
to effectively address both established and emerging cardiology market
A Broad Range of Cardiology Products and Services.
From individual devices designed to identify the early stages of heart
diseasesuch as Electrocardiographs, Cardiac Stress Testing Systems,
and Holter Monitorsto sophisticated systems that enable Cardiac
Rehabilitation and Cardiology Data Management, as well as life-saving,
innovative and patented automated external defibrillators (AEDs) for
both medical and non-medical markets, Cardiac Science Corporation
offers solutions across the entire continuum of cardiac care.
A variety of related products and supplies,
as well as superior customer and technical support through a comprehensive
portfolio of training, maintenance and service programs, are also
available to accommodate diverse budgets and needs.